As the academic partner and principal teaching site for Baylor College of Medicine, Texas Children’s is a global leader in pediatric education, training and innovation. With over $179 million in annual external research funding, 800,000-plus square feet of laboratory space, 90 newly discovered disease genes and over 400 active clinical trials, Texas Children’s drives breakthrough discoveries shaping the future of pediatric medicine. Its research enterprise is at the forefront of addressing neurological diseases, rare disorders and other high-impact conditions, where a single diagnosis can change outcomes for countless children. Texas Children’s and Houston-based University of Texas MD Anderson Cancer Center announced plans last year to integrate their pediatric cancer programs as Kinder Children’s Cancer Center, a landmark collaboration fueled by a transformational $150 million gift from Kinder Foundation and united around a singular mission of ending childhood cancer. This year, Texas Children’s completed a $200 million expansion of its Pavilion for Women, significantly increasing capacity for highly specialized maternal, fetal and neonatal care. It consistently ranks among the best pediatric hospitals by U.S. News & World Report, with all 10 ranked pediatric specialties among the nation’s top 10. Cardiology and heart surgery, neurology and neurosurgery, and pulmonology and lung surgery all rank No. 1 nationally, reflecting the depth of expertise and highly specialized care provided to patients from across the country and around the world.
